Posts Tagged ‘telehealth’

The twisted relationship of Hims and Novo Nordisk took another sharp turn this week. Novo withdrew its patent infringement lawsuit against Hims & Hers – barely a month after filing the suit. The company is now crowing about selling its Ozempic and Wegovy products through “leading telehealth providers” like Hims. But they “reserve the right […]

Recent news from Hims & Hers adds to our discomforting thought that compounded GLP-1s have become little more than a ploy to grab quick money from vulnerable consumers. Thursday, the company announced they are launching a compounded semaglutide tablet to compete with Wegovy. Reporting from Reuters suggests this announcement aimed to spark gains in their […]

We are in the midst of what used to be known as diet and weight loss season. And now the Super Bowl is coming up. Instead of diet ads this year, our video feeds are full of ads for telehealth and GLP-1s. Some of them are annoying. But when Serena Williams comes on screen to […]

Unless you’ve been living under a rock this January, you have probably noticed that this is no longer diet season. U.S. News seems to have abandoned their longstanding annual ranking of “Best Diets,” perhaps because no one is paying attention in this age of drugs related to Ozempic. Now, more people are dealing with excess […]

A big change is afoot and the hype is cranking up. With the launch of Wegovy tablets by Novo Nordisk yesterday, we are seeing some very big expectations expressed for a new era in obesity care. The stock market has boosted the value of Novo stock by 15 percent since FDA approved these tablets. Yesterday […]

We do not feel any nostalgia for “diet season.” None. Its demise was apparent two years ago. But in its place, it seems we have a telehealth GLP-1 season. Rebel Wilson is screaming at us to sign up for microdosing with a GLP-1. Put those ads together with somewhat calmer advertising from Ro and Hims, […]

The unmet need for delivering obesity care at scale is indisputably great. Just thinking about it is daunting because the need is so great. It will require new thinking. One thread of that new thinking is all of the innovation in telemedicine that’s unfolding before our eyes. In Obesity this month, we see yet another […]

There’s a long history on the tricky business of celebrity endorsements for weight management. Years ago, the benchmark was the Duchess of York, Sarah Ferguson, who became a spokesperson for Weight Watchers after her divorce from Prince Andrew. Proving much has changed in the popular conception of health and weight, the new benchmark is Serena […]

Mass market compounding of semaglutide and tirzepatide is pretty much a thing of the past. As that chapter in the story of inadequate access to care closes, it seems that Novo Nordisk is ready to go all in with telehealth deals to make up some lost ground. Their press release spells it out: “Today, Novo […]

A telehealth business has a slick, defiant commercial for their compounded weight loss medication ready to run during the Super Bowl tomorrow. More than a few doctors are definitely not amused. They are not the only ones. Two senators have written to the acting head of the FDA to say that caution and fair balance […]